| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 172.173 | - | - | 318.149 | - | 469.341 | 555.795 | 430.463 | 464.918 | 422.344 |
| Total Income - EUR | 173.411 | - | - | 318.162 | - | 469.345 | 555.798 | 430.467 | 464.920 | 423.296 |
| Total Expenses - EUR | 170.639 | - | - | 106.572 | - | 119.128 | 154.050 | 128.736 | 176.425 | 203.273 |
| Gross Profit/Loss - EUR | 2.772 | - | - | 211.590 | - | 350.217 | 401.748 | 301.731 | 288.495 | 220.023 |
| Net Profit/Loss - EUR | 1.307 | - | - | 208.409 | - | 345.781 | 396.430 | 297.426 | 283.846 | 190.973 |
| Employees | 3 | - | - | 3 | - | 4 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Gynecolife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.377 | - | - | 5.253 | - | 16.900 | 14.213 | 13.218 | 167.402 | 139.709 |
| Current Assets | 18.079 | - | - | 266.012 | - | 806.190 | 960.944 | 546.447 | 174.989 | 15.203 |
| Inventories | 1.644 | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.516 | - | - | 5.242 | - | 3.234 | 4.795 | 8.193 | 29.650 | 9.181 |
| Cash | 8.919 | - | - | 260.769 | - | 802.957 | 956.149 | 538.254 | 145.339 | 6.021 |
| Shareholders Funds | 41.068 | - | - | 250.120 | - | 812.046 | 956.406 | 56.199 | 213.522 | 79.937 |
| Social Capital | 45 | - | - | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.622 | - | - | 21.145 | - | 11.044 | 18.751 | 503.466 | 128.869 | 74.974 |
| Income in Advance | 0 | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gynecolife Srl